Insmed Inc Stock In The News
| INSM Stock | USD 75.16 0.72 0.95% |
Our overall analysis of Insmed's news coverage and content from conventional and social sources shows investors' bearish mood towards Insmed Inc. The specific impact of Insmed news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Insmed's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Insmed headlines in addition to utilizing other, more conventional financial analysis modules. Check out Insmed Backtesting and Insmed Hype Analysis.
Insmed |
Insmed Today Top News and Investor Outlook
Insmed Inc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Insmed and other traded companies coverage with news coverage. We help investors stay connected with Insmed headlines for the 29th of November to make an informed investment decision based on correlating the impacts of news items on Insmed Stock performance. Please note that trading solely based on the Insmed Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Insmed stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Insmed earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Insmed that are available to investors today. That information is available publicly through Insmed media outlets and privately through word of mouth or via Insmed internal channels. However, regardless of the origin, that massive amount of Insmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insmed alpha.
Insmed Largest EPS Surprises
Earnings surprises can significantly impact Insmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2013-08-06 | 2013-06-30 | -0.32 | -0.28 | 0.04 | 12 | ||
2015-05-07 | 2015-03-31 | -0.5 | -0.55 | -0.05 | 10 | ||
2014-05-08 | 2014-03-31 | -0.41 | -0.36 | 0.05 | 12 | ||
2013-11-05 | 2013-09-30 | -0.41 | -0.46 | -0.05 | 12 | ||
2012-08-07 | 2012-06-30 | -0.33 | -0.39 | -0.06 | 18 | ||
2011-11-08 | 2011-09-30 | -0.28 | -0.34 | -0.06 | 21 |
Insmed Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Insmed Inc Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
27th of November 2024
Insmed Incorporated Shares Sold by FORA Capital LLC at thelincolnianonline.com
19th of November 2024
Suvretta Capital Managements Strategic Acquisition in Benitec Biopharma Inc at gurufocus.com
15th of November 2024
Eversept Partners, LP Expands Stake in Community Health Systems Inc at gurufocus.com
6th of November 2024
Insmed To Present at November 2024 Investor Conferences at finance.yahoo.com
1st of November 2024
Decoding Insmed Inc A Strategic SWOT Insight at gurufocus.com
30th of October 2024
Insmed Q3 2024 Earnings Preview at seekingalpha.com
24th of October 2024
Insmed Ranks No. 1 on Sciences 2024 Top Biopharma Employers List at finance.yahoo.com
11th of October 2024
Disposition of 11900 shares by Michael Smith of Insmed at 17.16 subject to Rule 16b-3 at Michael Smith
27th of September 2024
Disposition of 730 shares by Michael Smith of Insmed at 70.05 subject to Rule 16b-3 at Michael Smith
13th of September 2024
Disposition of 26969 shares by Flammer Martina M.d. of Insmed at 34.03 subject to Rule 16b... at Flammer Martina M.d.
6th of September 2024
Disposition of 18874 shares by Flammer Martina M.d. of Insmed at 23.66 subject to Rule 16b... at finance.yahoo.com
Insmed Investors Sentiment
The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.
Check out Insmed Backtesting and Insmed Hype Analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.55) | Revenue Per Share 2.206 | Quarterly Revenue Growth 0.182 | Return On Assets (0.26) | Return On Equity (8.91) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.